therefore , we treated a group of thrombocythemic patients with ph-negative myeloproliferative disorders , including polycythemia vera and essential thrombocythemia , with recombinant interferon-alpha ( rifn-alpha 2a ) .
C0836924
thrombocythemic
C0040028
essential thrombocythemia